MacularorRetinalEdema near Elmhurst, NY

Care Philosophy: It is a privilege to care for New Yorkers, and patients from around the world, at Weill Cornell. As your doctor, I promise to listen, communicate, and provide exceptional, personalized care. I will work with you to create a customized treatment plan combining the most up-to-date, safe, and effective treatment options tailored to meet your individual priorities and goals. If surgery is necessary, I use minimally invasive or endoscopic approaches to reduce, or eliminate, scarring and recovery time.

Biography: Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma. Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008. Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr's efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy's Oncology and Pathology's One network.

Biography: Abdallah Mahrous, MD is an Assistant Professor in Ophthalmology at Weill Cornell Medicine and an Attending Physician at New York Presbyterian Hospital. He is a board-certified ophthalmologist specializing in vitreo-retinal surgery, a sub-specialty focused on diseases of the posterior segment of the eye including the vitreous cavity and the retina.Dr. Mahrous completed his two-year fellowship in vitreo-retinal surgery at Weill Cornell Medicine and New York Presbyterian Hospital. During his fellowship training Dr. Mahrous gained broad clinical and surgical experience treating patients across Weill Cornell Medicine clinics, New York Presbyterian Hospitals of Weill Cornell, Lower Manhattan, and Memorial Sloan Kettering Hospital.Prior to his fellowship training Dr. Mahrous completed a three-year ophthalmology residency also at Weill Cornell Medicine and New York Presbyterian Hospital where he gained exposure to various pathology across the New York Presbyterian Hospitals as well as Memorial Sloan Kettering Hospital. Dr. Mahrous also served as Chief resident in his senior year and won the prestigious Distinguished House Staff Award selectively chosen amongst the residents of New York Presbyterian Hospital for his clinical and surgical excellence.Dr. Mahrous is a graduate of Weill Cornell Medicine in Qatar where he received his Medical Degree with Honors in Academic Distinction where graduated top of his class and also received the United States Medical Licensure Examination Tutor award for his teaching and mentoring of junior medical students.Dr. Mahrous' clinical and surgical interests include diabetic retinopathy, macular degeneration, retinal detachments, retinal tears and holes, epiretinal membranes, macular holes, retinal vein occlusions and dislocated lenses amongst others. He is actively involved in clinical research and has contributed to numerous surgical, clinical and basic science peer-reviewed publications. He has also written journal review articles and helped author on several retina textbook chapters. He has also presented at local, national, and international ophthalmology conferences.

Biography: Dr. Sirikishan Shetty is a board certified Ophthalmologist practicing at NewYork-Presbyterian Queens located in Fresh Meadows, NY. He received his medical degree from the Medical College of Georgia Augusta University and completed his residency in Ophthalmology. Dr. Shetty is certified by the American Board of Ophthalmology and has been part of the NewYork-Presbyterian Queens staff since 2015.